VSee Health, Inc. (VSEE)
OTCMKTS · Delayed Price · Currency is USD
0.0160
-0.0060 (-27.27%)
At close: Aug 28, 2026

VSee Health Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
15.8114.6210.425.776.387.34
Revenue Growth
69.21%40.27%80.74%-9.59%-13.08%7.83%
Gross Profit
6.867.367.183.834.845.92
Operating Income
-10.84-9.58-4.68-1.79-1.460.25
Net Income
-9.89-14.71-57.7-3.76-0.840.48
Earnings Per Share
-0.26-0.73-5.65-0.38-0.080.05
EPS Growth
-----82.03%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Telehealth
8.437.242.22-
Technology
-7.388.25.77
Total
15.8114.6210.425.77

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.455.270.330.120.230.35
Total Debt
2.023.269.730.540.52-
Net Cash (Debt)
-1.572.01-9.4-0.42-0.290.35
Net Cash Growth
------46.05%
Net Cash Per Share
-0.040.10-0.92-0.04-0.030.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.31-3.45-5.79-0.63-0.83-0.46
Capital Expenditures
-0.03-0.03-0.06-0--
Free Cash Flow
-6.34-3.48-5.84-0.64-0.83-0.46
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
43.43%50.32%68.87%66.47%75.81%80.74%
Operating Margin
-68.56%-65.55%-44.94%-30.99%-22.96%3.44%
Pretax Margin
-85.13%-100.18%-569.46%-32.73%-25.40%5.27%
Profit Margin
-62.59%-100.65%-553.69%-65.26%-13.11%6.49%
FCF Margin
-40.09%-23.78%-56.08%-11.05%-12.95%-6.27%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----270.08
PS Ratio
0.061.012.0421.167.1017.52